Zhejiang East Asia Pharmaceutical's latest marketcap:
As of 07/06/2025, Zhejiang East Asia Pharmaceutical's market capitalization has reached $294.34 M. According to our data, Zhejiang East Asia Pharmaceutical is the 17801th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 294.34 M |
| Revenue (ttm) | 144.71 M |
| Net Income (ttm) | -18,373,987.83 |
| Shares Out | 112.57 M |
| EPS (ttm) | -0.16 |
| Forward PE | 8.48 |
| Ex-Dividend Date | 07/04/2024 |
| Earnings Date | 08/29/2025 |
Zhejiang East Asia Pharmaceutical's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/06/2025 | ¥294.34 M | -4.94% | 17801 |
| 12/31/2024 | ¥2.22 B | -26.27% | 16342 |
| 12/29/2023 | ¥3.01 B | 32.27% | 14102 |
| 12/30/2022 | ¥2.27 B | -27.57% | 14946 |
| 12/31/2021 | ¥3.14 B | -22.14% | 13450 |
| 12/31/2020 | ¥4.03 B | 10478 |
Company Profile
About Zhejiang East Asia Pharmaceutical Co., Ltd.
Zhejiang East Asia Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the production and sale of a diverse range of medical products. Established in 1992 and headquartered in Taizhou, China, the company serves both domestic and international markets.
Product Portfolio
- Pharmaceutical Chemicals & Intermediates
- Dosage Forms: Tablets, Granules, Capsules
- Therapeutic Categories:
- Quinolones Synthetic Antibacterial Agents
- Antifungal Products
- Gastrointestinal Medications
- Semi-Synthetic Cephalosporin Antibiotics
- Carbapenem Antibiotics
- Antiviral Agents
- Central Nervous System Medications
- Respiratory Drugs
- Antiallergic Agents
- Antineoplastic Agents & Tumor Adjuvant Drugs
Key Therapeutic Fields
- Cardiovascular
- Anti-Aging Dementia
- Digestive System
- Diabetic Neuropathy
- Anti-Pathogenic Microorganisms
Global Reach
The company operates a robust sales network, serving customers across:
- China
- Europe
- United States
- Southeast Asia
- Other International Markets
Frequently Asked Questions
-
What is Zhejiang East Asia Pharmaceutical's (SHA-605177) current market cap?As of 07/06/2025, Zhejiang East Asia Pharmaceutical (including the parent company, if applicable) has an estimated market capitalization of $294.34 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Zhejiang East Asia Pharmaceutical (SHA-605177) rank globally by market cap?Zhejiang East Asia Pharmaceutical global market capitalization ranking is approximately 17801 as of 07/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.